Cytokines clearance during venovenous hemofiltration in the trauma patient

American Journal of Kidney Diseases

Volumn 30, Issue 4, 1997, Pages 483-488

  Sanchez Izquierdo Riera, J A ^a,b   Perez Vela, J L ^a   Lozano Quintana, M J ^a   Alted Lopez, E ^a   Ortuno De Solo B ^a   Ambros Checa, A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b NONE   (Spain)

Author keywords

Continuous venovenous hemofiltration; Cytokines; Mediators clearance; Multiple organ dysfunction; Trauma

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; HEMOFILTRATION; HUMAN; INFLAMMATION; MULTIPLE ORGAN FAILURE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TRAUMATOLOGY;

EID: 12644315043     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90305-X     Document Type: Article

References (29)

1. Baker CC, Oppenheimer L, Stephens B, Lewis FR, Trunkey DD: Epidemiology of trauma deaths. Am J Surg 140:144-151, 1980
2. Meade P, Shoemaker WC, Donnelly TJ, Abraham E, Jagels MA, Cryer HG, Hugh TE, Bishop MH, Wo ChCJ: Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J Trauma 36:651-657, 1994
3. Svoboda P, Kantorova I, Ochmann J: Dynamics of interleukin 1,2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 36:336-340, 1994
4. Moscovitz H, Shofer F, Mignott H, Behrman A, Kilpatrick L: Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 22:1102-1107, 1994
5. Van der Meer JWM, van Deuren M, Kullberg BJ: The interplay of proinflammatory cytokines and anti-inflammatory mediators during severe infection, in Vincent JL (ed): Year Book of Intensive Care and Emergency Medicine. Springer Verlag, Berlin, Germany, 1995, pp 377-384
6. Mehta RL: Continuous hemofiltration/dialysis: Current status and future directions. Nefrologia 12:276-286, 1992 (suppl 4)
7. Goris RJA, Boekhorst TPA, Nuytinck JKS, Gimbrere JSF: Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 120:1109-1115, 1985
8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 13:818-829, 1985
9. Baker SP, O'Neill B: The injury severity score: An update. J Trauma 16:882-885, 1976
10. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello ChA: Interleukin-1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effects of cyclooxygenase inhibitors. J Clin Invest 81:1162-1172, 1988
11. Waage A, Espevik T: Interleukin-1 potentiates the lethal of tumor necrosis factor-alpha/cachectin in mice. J Exp Med 167:1987-1992, 1988
12. Fong YM, Lowry SF: Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol 55:157-170, 1990
13. Michie HR, Manogue MB, Spriggs DR, Revhang A, O'Dwyer S, Dinarello CA, Cerami A, Wolf SM, Wilmore DW: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486, 1988
14. Offner F, Philippe J, Vogelaers D, Colardyn F, Baele G, Baudrihaye M, Vermeulen A, Leroux-Roels G: Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 116:100-105, 1990
15. Calandra T, Gerain J, Heumann D, Daumgartner JD, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 91:23-28, 1991
16. Hack CE, De Groot ER, Felt-Bersma JF, Nuijens JH, Strack RJM, Eerenberg AJM, Thijs LG, Aarden CA: Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710, 1989
17. Bone RC: Sepsis and its complications: The clinical problem. Crit Care Med 22:S8-S11, 1994 (suppl)
18. Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P: Removal of proinflammatory therapy: Sense or non sense? Intensive Care Med 21:169-176, 1995
19. Sanchez-Izquierdo Riera JA, Ambrós Checa A, Lozano Quintana MJ, Ortuño B, Pérez Vela JL, Alted López E: Eliminación de TNF en patientes criticos con hemofiltración contínua. Med Intensiva 18:S6, 1994 (abstr; suppl)
20. Bellomo R, Tipping P, Boyce N: Continuous venovenous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21:522-526, 1993
21. Brown A, Mehta RL: Effect of CAVH membranes on transmembrane flux of TNF-alpha. Proceedings of the American Society of Nephrology, 1991, p 316 (abstr)
22. Bellomo R, Tipping P, Boyce N: Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. ASAIO Trans 37:322-323, 1991
23. McDonald BR, Mehta RL: Transmembrane flux of IL-1 beta and TNF alpha in patients undergoing continuous arteriovenous hemodialysis. J Am Soc Nephrol 1:56, 1990 (abstr)
24. Lonneman G, Schindler R, Dinarello CA, Koch KM: Removal of cytokines by hemodialysis membrane in vitro, in Faist E, Meakins J, Schildberg FW (eds): Host Defense Dysfunction in Trauma, Shock and Sepsis. Berlin, Germany, Springer, 1993, pp 613-623
25. Kierdorf H, Melzer H, Weissen D, Heintz B, Sieberth HG: Elimination of tumor necrosis factor alpha (TNF-alpha) by continuous venovenous hemofiltration. Ren Fail 14:98, 1992 (abstr)
26. Herbelin A, Nguyen AT, Urena P, Descamps-Latscha B: Induction of cytokines by dialysis membranes in normal whole blood: A new in vitro assay for evaluating membrane biocompatibility. Blood Purif 10:40-52, 1992
27. Golper TA, Vincent HH, Gleason JR, Vos MC: Drug removal during high efficiency and high-flux hemodialysis. Contemp Issues Nephrol 27:175-208, 1993
28. Vincent HH, Akcahuseyn E, Goessens WHF, Van Duyl WA, Schalekamp MADH: Drug clearance by continuous hemodiafiltration (CAVHD). Analysis of sieving coefficient and mass transfer coefficients of diffusion. Blood Purif 11:99-107, 1993
29. Van Bommel EFH, Hesse CJ, Jutte NHPM, Zietse R, Braining HA, Weimar W: Cytokine kinetics (TNF-alpha, IL-1, IL-6) during continuous hemofiltration: A laboratory and clinical study. Contrib Nephrol 116:62-75, 1995